Alex Jones: A Controversial Return to Social Media Platform X
The social media landscape witnessed a significant development as controversial conspiracy theorist Alex Jones marked his return to platform X, formerly known as Twitter, by [more…]
Which companies could make the gains amid a pumping global fitness sector?
Projections for global health and fitness sectors indicate a continual upward trend as people prioritise their wellbeing Increase in mixed martial arts (MMA) participants, fuelled [more…]
FREE WHELAN: What happened if you kept the faith in 2023
In this Stockhead series, investment manager James Whelan, managing director Barclay Pearce Capital Asset Management, offers his insights on the key investment themes and trends in domestic [more…]
Dr Boreham’s Crucible: Excessive sweater? Botanix is here to get you fit for public consumption again
Botanix (ASX:BOT) has renounced the weed. Unlike rapper and enthusiastic lifetime cannabis consumer Snoop Dog, however, this time it’s for real. A current inhabitant of [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to Tuesday, December 12 – a date on the calendar of massive importance to the World of Art, as today [more…]
Canada Unearthed: Want proper uranium exposure? Look no further
Spot uranium price is at 16-year highs driven by strong physical market demand; long term outlook also strong TSX is home to some of the [more…]
ASX Large Caps: ASX closes flat after losing ground and weighed down by miners
ASX closes flat as miners weigh on market as energy stocks lead winners Chemist Warehouse plans to list on the ASX via a merger with [more…]
Closing Bell: The ASX is spectacularly flat on Monday
The ASX benchmark has been a bit of a pushover on Monday Energy Sector makes sunshine-hay Small caps led by LTR Pharma and West Cobar [more…]
Monsters of Rock: Dragged through a hedge backwards? Not anymore, Regis says
450,000ozpa gold miner Regis could make an extra $180m a year now it is hedge-free The mid-tier producer has been chipping away at massive hedging [more…]
In Case You Missed It: A happy pharma debutante, plus positive news for a bunch of explorers
Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing [more…]
